AXA PPP healthcare has removed all limits on its
cover for licensed cancer drugs on its standard medical insurance policies for
individuals and small businesses.
Accepting that heart disease and cancer are the
two health problems that worry people most, and that both conditions that have
seen dramatic improvements in treatment and survival rates over the last few
years, the insurer sees the need to cover new treatments and drugs. With
increasing survival times, people are more likely to need treatment and care
for longer.
The insurer promises to meet customer needs at
all stages of cancer and for heart surgery. It will provide access to the very
latest in treatment, drugs, agreed clinical trials, support and care for
cancer.
It will cover treatment of cancer at every stage-
no matter what path it takes, even if it recurs or spreads. Will pay for new
cancer drugs as soon as they are licensed and not wait for decisions from other
bodies such as National Institute for Health and Clinical Excellence.
As well as covering all existing licensed cancer
drugs, also cover experimental drugs when part of an ethically approved trial.
If offered an experimental treatment other than drugs, the insurer will
consider that too.
Includes palliative care for cancer with no time
limits or session limits on out-patient consultations for cancer.
Has extended one-to-one dedicated nurse service
to cover customers having heart surgery as well as cancer.
Will give a £100 donation to a hospice charity
for every night a customer receives hospice care.
Extra expenses for cancer treatment include up to
£5,000 for external prostheses during active treatment, and up to £150 for
wigs.
Will cover cancer treatment including
secondaries;chemotherapy and radiotherapy; biological therapies, bone scans, bisphosphonate
and hormone treatment.
Will cover specialist consultation visits for
follow ups without time limit.
Where customers have out-patient benefit limited
to specified cash limit cancer treatment costs will not be taken from this
limit.
Will continue to cover customers throughout all
stages of their cancer, even if it becomes terminal.
For heart surgery follows ups, there is now no
time limits for follow ups for coronary heart bypass, cardiac valve treatment,
implantable devices such as defibrillators and pacemakers, or coronary
angioplasty.
Private medical insurance news: 20 January 2012
